October 24, 2025
Meet the Medicare Bad Debt Team
At Blue & Co., we believe that our greatest strength lies in our people. Each member of our Medicare Bad Debt team brings a unique blend of expertise, experience, and […]
Read MoreCategory: Medicare Bad Debt
July 31, 2025
Medicare Bad Debt Crossover Potential Revealed
Beginning June 7, 2024, Indiana Medicaid launched a transformative new program: PathWays, a managed long-term service and support (MLTSS) initiative designed to streamline care for aging Hoosiers. This program partners […]
Read MoreMay 23, 2025
Filing Medicare Bad Debt Listings With Medicare Advantage Plans
Are you maximizing your reimbursement potential with Medicare Advantage (MA) plans? Many healthcare providers are unaware that they can file bad debt listings for additional reimbursement. The key lies in […]
Read MoreMarch 6, 2025
Medicare Cost Report Appeal Types & How to Navigate the Appeals Process
To appeal or not to appeal: that is the question. Medicare cost report appeals can be extremely profitable, but which issues are worth the time and effort to appeal? Without […]
Read MoreSeptember 7, 2023
Changes to Medicare Bad Debt and S-10 Template Effective this Month
The new Medicare Bad Debt template (Exhibit 2A) and S-10 template (Exhibit 3B and 3C) have been finalized by Medicare and are now required for cost reporting periods ending on […]
Read MoreJanuary 5, 2023
Medicare Bad Debt Listing Template Finalized by CMS
This article has been updated on January 5, 2023. Back in August 2022, CMS was proposing changes to the Medicare Bad Debt listing template that is filed with your organization’s […]
Read MoreFebruary 9, 2021
Medicare Administrative Contractors: Audit Trend
How to Protect Dual Eligible Reimbursement from Audit Scrutiny In the past year, there has been a new audit trend emerging amongst MACs (Medicare Administrative Contractors). In some cases, this […]
Read MoreNovember 4, 2020
CMS Updates Language on Medicare Bad Debt Crossover Write Off
Since the release of Centers for Medicare & Medicaid (CMS) final ruling, there has been a lot of confusion regarding the correct way to write off a bad debt crossover […]
Read MoreOctober 22, 2020
Medicare Bad Debts Regulations Update: October 2020
In these unprecedented times, protecting your Medicare bad debt reimbursement is more important than ever. With decreases in patient volume due to COVID-19, hospitals will certainly feel the effect on […]
Read MoreSeptember 10, 2020
CMS Finalized Ruling- Medicare Bad Debt Summary
On September 2, 2020, CMS released its final ruling. It is effective beginning October 1, 2020, for FY 2021. This means it will go in to effect the first day […]
Read MoreRecent Articles View All Thought Leadership
January 13, 2026
The deadline for hospitals to submit the Occupational Mix Survey is June 30, 2026. The Centers for Medicare and Medicaid Services (CMS) collects this data every three years on the […]
January 13, 2026
Outsourcing is a common practice in all areas of business, including the healthcare sector. Although this is a major expense for a hospital, it can influence the wage index factor […]
January 12, 2026
The Centers for Medicare & Medicaid Services (CMS) Low Volume Payment Adjustment attestation period has been extended. Congress recently passed a short-term temporary extension, extending the deadline to January 30, […]
Kristina Lakins’ experience highlights the commitment Blue & Co. makes to developing strong, thoughtful leaders. Through Blue’s first ACCELERATE! cohort, Kristina is sharpening her leadership and strategic skills while growing as a manager. We appreciate Kristina for embracing this opportunity and exemplifying a passion for continuous growth.![]()
![]()
![]()
![]()
![]()
![]()
To learn more about what makes Blue & Co. such a great place to work, head to hubs.la/Q03Y99Ft0.
As the dental industry continues to learn the vernacular of dental service organizations, one financial term has taken center stage: EBITDA. While EBITDA is often touted as a key indicator of practice value or practice performance, it is frequently misunderstood and misapplied. In this article, Blue & Co. experts break down what EBITDA really means, why normalized compensation matters, and how these figures can influence practice ownership, valuations, and the way you evaluate your Practice. Before you rely on EBITDA alone, discover its uses, limitations, and why it should be just one tool in your financial toolkit.![]()
![]()
![]()
![]()
![]()
![]()
Read the full article:
Quick Links
Copyright © 2026, Blue & Co., LLC.
All Rights Reserved.